Publicacións (142) Publicacións de Francisco Campos Pérez

2024

  1. Modulation of Abundance and Location of High-Mobility Group Box 1 in Human Microglia and Macrophages under Oxygen-Glucose Deprivation

    ACS Pharmacology and Translational Science, Vol. 7, Núm. 3, pp. 680-692

  2. New Perspectives in Neuroprotection for Ischemic Stroke

    Neuroscience

  3. Systemic biomarker associated with poor outcome after futile reperfusion

    European Journal of Clinical Investigation

  4. Thrombolytic therapy based on lyophilized platelet-derived nanocarriers for ischemic stroke

    Journal of Nanobiotechnology, Vol. 22, Núm. 1

2023

  1. Influence of Temperature Chronobiology on Stroke Outcome

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

  2. Magnetic separation and concentration of Aβ 1–42 molecules dispersed at the threshold concentration for Alzheimer’s disease diagnosis in clinically-relevant volumes of sample

    Journal of Nanobiotechnology, Vol. 21, Núm. 1

  3. Periodontitis is associated with subclinical cerebral and carotid atherosclerosis in hypertensive patients: A cross-sectional study

    Clinical Oral Investigations, Vol. 27, Núm. 7, pp. 3489-3498

2022

  1. 3D printed carboxymethyl cellulose scaffolds for autologous growth factors delivery in wound healing

    Carbohydrate Polymers, Vol. 278

  2. A Polygenic Risk Score Based on a Cardioembolic Stroke Multitrait Analysis Improves a Clinical Prediction Model for This Stroke Subtype

    Frontiers in Cardiovascular Medicine, Vol. 9

  3. Antihyperthermic Treatment in the Management of Malignant Infarction of the Middle Cerebral Artery

    Journal of Clinical Medicine, Vol. 11, Núm. 10

  4. Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke

    Journal of Clinical Medicine, Vol. 11, Núm. 4

  5. Fibrin-Targeted Nanoparticles for Finding, Visualizing and Characterizing Blood Clots in Acute Ischemic Stroke

    Pharmaceutics, Vol. 14, Núm. 10

  6. Involvement of Ceramide Metabolism in Cerebral Ischemia

    Frontiers in Molecular Biosciences, Vol. 9

  7. Multi-Ancestry GWAS reveals excitotoxicity associated with outcome after ischaemic stroke

    Brain, Vol. 145, Núm. 7, pp. 2394-2406

  8. Need for a Paradigm Shift in the Treatment of Ischemic Stroke: The Blood-Brain Barrier

    International Journal of Molecular Sciences, Vol. 23, Núm. 16

  9. Neurological Instability in Ischemic Stroke: Relation with Outcome, Latency Time, and Molecular Markers

    Translational Stroke Research, Vol. 13, Núm. 2, pp. 228-237

  10. New Perspectives for Developing Therapeutic Bioconjugates of Metabolite-Depleting Enzymes: Lessons Learned Combating Glutamate Excitotoxicity

    Biomacromolecules

  11. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  12. Sonosensitive capsules for brain thrombolysis increase ischemic damage in a stroke model

    Journal of Nanobiotechnology, Vol. 20, Núm. 1

  13. Stress Granules and Acute Ischemic Stroke: Beyond mRNA Translation

    International Journal of Molecular Sciences, Vol. 23, Núm. 7